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A cluster of six pediatric cases of deep-seated Staphylococcus aureus  
infection after heart operations prompted us to perform molecular typing of 
the S. aureus  isolates by pulsed-field gel electrophoresis. This revealed the 
presence of genotypically distinct isolates in four of the six patients. 
Isolates of two patients were genotypically identical. All patients carried S. 
aureus  in the anterior nares. In each patient, the handing pattern of 
deoxyribonucleic acid in these isolates was indistinguishable from that in 
strains isolated from blood or wound cultures. Molecular typing with 
pulsed-field gel electrophoresis ruled out nosocomial transmission of S. 
aureus  between four patients; at the same time, it provided evidence for an 
association between nasal colonization and postoperative wound infection. 
Epidemiologic investigation of potential links between two patients with 
identical isolates did not provide any evidence for nosocomial transmission 
of S. aureus  between these patients. Because nasal colonization with S. 
aureus  may be a risk factor for surgical wound infection in pediatric 
patients undergoing heart operations, preoperative decolonization appears 
to he warranted. (J Thorac Cardiovasc Surg 1996;112:681-6) 
The spectrum of sternal wound infections after 
/hear t  operations ranges from superficial infec- 
tions to severe, deep-seated infections. 1 The latter 
usually necessitate both surgical intervention and 
prolonged parenteral antibiotic therapy. Because of 
the potential seriousness of this complication, mea- 
sures to reduce the risk of sternal wound infection 
are important. These include preoperative antibiotic 
prophylaxis, sterile surgical technique, and skin dis- 
infection at the surgical site. 
A cluster of six pediatric cases of deep-seated 
Staphy lococcus  aureus  infection after heart opera- 
tions prompted us to perform molecular typing of 
the S. aureus  isolates cultured from blood and from 
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swabs from the sternal wound, various skin folds, 
throat, and nares. Surprisingly, our investigations 
(which were carried out for hospital infection con- 
trol reasons) revealed nasal carriage of S. aureus  
with genotypes identical to those of the respective 
isolates from blood and sternal wound in all pa- 
tients. These results and the recently documented 
association of S. aureus  nasal carriage with an 
increased risk of sternal wound infection 2 raise a 
question regarding whether preoperative nasal de- 
colonization is warranted as a prophylactic measure 
for all patients undergoing sternotomy. 
Patients and methods 
Patients. Patients with clinical evidence of S. aureus 
sternal wound infection after heart operations at the 
University Hospital of Zurich between January and May 
1995 were included in this report. On suspicion of sternal 
wound infection, swabs or specimens of clinically relevant 
body sites or body fluids, as well as wab samples from 
nares, throat, axilla, and inguinal folds, were obtained for 
bacterial culture. 
Microbiologic analysis. S. aureus was isolated and sus- 
ceptibility testing was performed with standard microbio- 
logic procedures. 
Molecular typing. Pulsed-field gel electrophoresis 
(PFGE) was performed essentially as described y Back 
and coworkers, 3 with some minor modifications as fol- 
lows: After overnight growth of S. aureus isolates in laked 
blood broth, the bacteria were centrifuged to form pellets, 
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Table I. Synopsis of six children with congenital heart disease and sternum osteomyelitis after cardiac 
operations 
Bypass time Postoperative Signs of ternal wound 
Patient Sex Age Underling disease Surgical procedure (min ) course infection 
1 Boy 16 Transposition of great Hemi-Fontan, liga- 140 Low-output syn- Day 24 after operation: 
mo arteries, pulmonary tion of Blalock- drome, supraven- fever, tachypnea a d 
atresia, mitral atre- Taussig shunt tricular arrhyth- tachycardia, local 
sia, atrial septal mias, thrombosis swelling, hyperemia, 
defect, Blalock- of femoral artery and tenderness 
Taussig shunt 
2 Girl 14 Tetralogy of Fallot, Complete surgical 181 Low-output syn- Day 20 after operation: 
mo Down syndrome repair drome fever; local swelling, 
3 Boy 9 yr 
hyperemia, and ten- 
derness 
Day 4 after operation: 
fever, purulent dis- 
charge from sternal 
wound 
Congeifital aortic 
valve stenosis, aor- 
tic insufficiency 
(surgical valvulo- 
plasty at 6 months) 
4 Gift 5 Tricuspid atresia, 
mo ASD, PDA; Bla- 
lock-Taussig shunt 
at 1 day 
5 Boy 4 yr VSD repair at 3
months; pulmonary 
stenosis 
6 Boy 1 Interrupted aortic 
mo arch, VSD, PDA 
Ross procedure 89 Rethoracotomy for 
with pulmonary major bleeding on 
homograft day 1; sternum 
closure on day 2; 
surgical removal 
of wound drain- 
age on day 5; re- 
current atelectasis 
of left lung 
Blalock-Taussig 0 Recurrent atelecta- 
shunt sis, pleural effu- 
sion; cardiac fail- 
ure 





Resection of co- 100 Low cardiac output, 
arctafion, end- seizures, renal 




Day 24 after operation: 
fever, drainage from 
sternal wound 
Day 21 after operation: 
fever, local swelling, 
hyperemia, tender- 
ness 
Day 18 after operation: 
fever, local swelling, 
hyperemia 
ASD, Atrial septal defect; PDA, patent ductus arteriosus; VSD, ventricular septal defect. 
which were resuspended and mixed with 2% low-melt 
agarose and lysostaphin at 45 ° C. Agarose plugs were 
incubated with lysozyme, followed by digestion of bacte- 
rial deoxyribonucleic a id with SmaI. 
PFGE was performed with a 1% agarose gel in 0.5× 
Tris-boric acid-ethylenediaminetetraacetic id buffer at 
12 ° C. Run conditions of the CHEF DR III system 
(Bio-Rad, Glattbrugg, Switzerland) were 5 volts at an 
included angle of 120 degrees from an initial switch time 
of 5 seconds to a final switch time of 60 seconds. The run 
was terminated after 24 hours, and the gel was photo- 
graphed after staining with ethidium bromide. Banding 
patterns were compared visually. According to criteria 
published by Tenover and associates, 4 strains were con- 
sidered genotypically indistinguishable if their restriction 
patterns had the same number of bands and the same 
apparent size. 
Results 
Clinical course. During the course of 5 months, we 
observed six pediatric patients with deep-seated ster- 
nal wound infections. A synopsis of the underlying 
diseases, surgical procedures, clinical presentation, mi- 
crobiologic assessment, a tibiotic regimens, and out- 
comes is given in Table I. The patients received 25 
mg/kg intravenous cefazolin 30 to 60 minutes before 
operation. Although most patients had uneventful 
surgical courses, patient 3 had major venous bleeding 
at the surgical site and required packing of the wound 
and secondary closure of the sternum. The sternum of 
patient 6 was closed on the first postoperative day 
because of low cardiac output. 
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Bacterial 
isolates Treatment Outcome 
S. aureus cultured from Surgical drainage, intra- Cured 
blood and swabs venous vancomycin 
from sternal wound, and gentamicin for 2 
throat, and nares days, then switch to 
intravenous fluclox- 
acillin for 4 weeks 
S. aureus cultured from Surgical drainage, intra- Cured 
blood and swabs venous flucloxacillin 
from sternal wound for 4 weeks 
and nares 
S. aureus cultured from Surgical drainage, genta- Cured 
blood, sternal micin implants, intra- 
wound, axilla, throat, venous flucloxaciUin 
inguinal fold, and for 4 weeks 
nares  
S. aureus cttlmred fxom Intravenous flucloxacil- 
sternal wound, ingui- lin for four weeks; 
nal fold, throat, and intermittent amoxicil- 
nares lin- clavulanic acid 
S. aureus cultured from Surgical drainage; intra- 
sternal wound and venous flucloxacillin 
nares for 2 weeks 
Died 2 weeks 
later of car- 
diac failure 
Cured 
S. aureus cultured from 
sternal wound, ve- 




acid (4 weeks) and 
intravenous aminogly- 
coside (2 weeks), gen- 
tamicin implants 
Signs and symptoms suggesting sternal wound infec- 
tion became apparent between 4 and 24 days after 
operation (Table I). All six patients were febrile up to 
a temperature of 41 ° C, had leukocytosis with leuko- 
cyte counts between 19,600 and 24,000 cells//zl, and 
had elevated levels of C-reactive protein ranging from 
40 to 175 rag/1 (normal < 5 rag/l). In all six cases, S. 
aureus was recovered from the sternal wound. Three 
patients had blood cultures positive for this organism. 
Surgical revision of the sternum and a 4-week course 
of intravenous flucloxacillin (100 mg. kg -1 • day -I) or 
amoxicillin-clavulanic a id in combination with an 
aminoglycoside r sulted in complete recovery in five 
cases. One patient died of cardiac failure 2 weeks after 
cessation of antibiotic therapy, without evidence for 
recurrence or persistence of sternal wound infection. 
During the same 5-month period 60 surgical repairs 
with bypass were performed in pediatric patients. 
There was no correlation between bypass time and 
occurrence of sternal wound infection (data not 
shown). 
Recovery of S. aureus. The results of bacterial 
cultures done on suspicion of sternal wound infec- 
tion are presented in Table II. S. aureus was recov- 
ered from the sternal wound and nares in all six 
patients. Furthermore, S. aureus was isolated from 
throat swabs in patients 1, 3, and 4 and also from the 
axilla or inguinal fold in patients 3 and 4 (Tables I
and II). The susceptibility patterns of the isolates of 
five of the six patients were identical. The isolates 
from patient 6 were sensitive to all antibiotics tested, 
including ampicillin. All other isolates were resistant 
to ampicillin but uniformly sensitive to oxacillin, 
flucloxacillin, cefazoline, gentamicin, amikacin, van- 
comycin, teicoplanin, and mupirocin. 
Genotype pattern. Molecular genotyping by 
PFGE revealed that the S. aureus isolates from 
sternal wound and nares were identical for each 
patient but differed among patients, except for 
isolates from patients 2 and 4, which showed indis- 
tinguishable banding patterns (Fig. 1). As shown in 
Fig. 1, S. aureus isolated from blood (patients 1 
through 3), skin (patient 4), and entry site of a 
venous catheter (patient 6) were genotypically iden- 
tical with the strains isolated from the sternal 
wounds and nares of individual patients. On the 
other hand, the throat isolate of patient 1 was 
genotypically distinct from the other isolates from 
that patient (not shown). 
Epidemiologic investigation of possible modes of 
transmission between patients 2 and 4. Although 
the same two members of the surgical department 
performed the surgical procedures on both patients, 
there was an interval of more than 3 months 
between the two operations. No common source 
of the S. aureus strain isolated from both patients 
was apparent. 
Discussion 
We observed a cluster of deep-seated sternal 
wound infections after heart operations i  pediatric 
patients. The infections were significant in all six 
patients, resulting in bacteremia in three patients 
and necessitating surgical drainage in all but one. 
Preoperative antibiotic prophylaxis was used in all 
cases. Despite the fact that the infections occurred 
over a period of less than 5 months, the results of 
molecular typing by PFGE ruled out nosocomial 
transmission of S. aureus between patients in four of 
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Table II. Recovery of  S. aureus in patients with sternal wound infection after heart operations 
Bacterial cultures for S. aureus 
Site Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 
Blood Positive Positive Positive Negative Negative Negative 
Sternal wound Positive Positive Positive Positive Positive Positive 
Nares Positive Positive Positive Positive Positive Positive 
Throat Positive* Negative Positive Positive Negative ND 
Axilla Negative Negative Positive Negative Negative Negative 
Inguinal fold Negative Negative Positive Positive Negative Negative 
Patient 6 had S. aureus i olated at insertion site of v nous catheter. ND, Not done. 
*Genotype distinct from genotype of the other isolates from the same patient. 
the six cases. Each of these four patients was colonized 
and infected with a distinct isolate (Fig. 1). 
Two patients had genotypically identical isolates, 
but nosocomial transmission between these two 
patients i  unlikely because they had no contact and 
were hospitalized uring two separate months. 
Transmission originating from a common source, 
such as a carrier of S. aureus is an obvious concern. 
Our epidemiologic investigation discovered thattwo 
members of the health care team were involved in 
surgery and perioperative care in both cases. Both 
persons perform surgical procedures regularly and 
have not been found to be nasal carriers of this 
particular genotype of S. aureus; however, transmis- 
sion from ancillary staff cannot be completely ruled 
out because medical records list only professionals 
directly involved in anesthesia and surgery. So far no 
additional cases of wound infection caused by this 
genotype have been detected. Because nasal cul- 
tures were not routinely obtained from all patients 
undergoing heart operations, we cannot exclude the 
possibility that additional patients who did not ac- 
quire infectious complications were also colonized 
with one or more of these strains. Colonization of 
the two patients with this particular strain during the 
preoperative stay in the Children's Hospital must 
also be considered. 
An intriguing aspect of this case series is the fact 
that nasal colonization by S. aureus with a genotype 
identical to the genotype of isolates recovered from 
the sternal wound, and in some cases also blood and 
other sites, was present in all cases. At this point, it 
remains peculative whether nasal colonization was 
present before onset of infection or whether nasal 
colonization was the result of secondary spread from 
an infected site. Nonetheless, the role of S. aureus 
nasal colonization as a risk factor for the develop- 
ment of sternal wound infection after heart opera- 
tions has recently been reported. 2 During a 3-year 
period, 1980 patients undergoing elective heart op- 
erations were screened for nasal carriage of S. 
aureus before operation. Nasal carriage ofS. aureus 
was significantly associated with the development of 
wound infection (odds ratio 9.6, confidence interval 
3.9 to 23.7) compared with a control population 
without surgical wound infection. The phage typings 
of the available preoperative and postoperative iso- 
lates were identical. The other elevant risk factor in 
this study was insulin-dependent diabetes mellitus. 2 
A similar prospective study is currently planned to 
investigate whether preoperative screening and de- 
colonization of pediatric patients would result in a 
reduced rate of postoperative infections by S. au- 
reus. This study will also examine possible risk 
factors for nasal colonization, such as prolonged 
preoperative hospital stay, prolonged intubation, 
stay in intensive care unit, antibiotic use, and contact 
with colonized health care workers. 
Similar linkage of nasal carriage of S. aureus with 
postoperative wound infection was demonstrated by 
two studies published in 1959. Williams and cowork- 
ers, 5 reporting on 722 patients, observed that the 
wound infection rate was 2% among patients with- 
out nasal carriage of S. aureus and 7.1% among 
carriers of S. aureus. Although this study did not 
specify the types of surgical procedures performed, s 
Weinstein 6 reported on 125 procedures, 101 of 
which involved the lung. Again, the wound infection 
rate was lower (1.2%) in the group with negative 
bacterial cultures of the nose than in the group with 
positive bacterial cultures (11.7%). Comparison of 
bacterial isolates by phage typing showed that the 
strains recovered from the infected wound and from 
the nares were identical. 6 The rate of nasal carriage 
was 34% in Weinstein's study 6and 38% in the study 
published by Williams and coworkers, 5 who in addi- 
tion demonstrated that nasal carriage rate increased 
with prolongation of the preoperative hospital stay. 
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A more recent study in a surgical intensive care unit 
also demonstrated that nasal colonization by S. 
aureus was associated with a higher ate of infection 
caused by this organism] The observation that the 
systematic use of mupirocin nasal ointment in all 
patients admitted to the unit was temporarily asso- 
ciated with a significant reduction in the incidence of 
S. aureus infections lends further support to the 
postulate that nasal colonization precedes rather 
than follows colonization or infection at other body 
sites] The indiscriminate use of mupirocin in all 
patients admitted to intensive care units cannot be 
recommended, however, because such a practice 
might facilitate the development of resistance, s 
Nasal colonization as a risk factor for infection at 
a distant site is not unique to surgery, however. 
Increased rates of infection in nasal carriers of S. 
aureus have been reported in patients infected with 
human immunodeficiency virus, 9 users of illicit in- 
travenous drugs, I° persons with diabetes, 11 and pa- 
tients undergoing hemodialysis 12-14 or peritoneal 
dialysis. 15 
In patients undergoing hemodialysis, attempts at 
nasal decolonization by topical decontamination 
with mupirocin have been successfulJ 3 Mupirocin 
has been shown to effectively eradicate nasal car- 
riage of methicillin-resistant S. aureus in most car- 
riersJ 6 It is well tolerated and does not cause any 
significant side effects. 17 The development of resis- 
tance in settings where this compound is used 
widely, however, may limit its usefulness in the 
future. 18 
To avoid the spread of mupirocin resistance as a 
result of wide use of this compound, the clinical 
indications for use should be clearly defined. A 
recent study by Kluytmans, Vandenbergh, and Ver- 
brugh 19 indicates that mupirocin treatment may 
indeed result in a reduction of the rate of postoper- 
ative wound infections after heart operations. Con- 
ceivably, preoperative screening of patients followed 
by mupirocin treatment of nasal carriers of S. aureus 
could be a useful strategy to reduce surgical wound 
infections. Alternatively, certain risk groups could 
be targeted for screening, including patients with 
diabetes or renal insufficiency and pediatric patients 
with congenital heart disease. Patients in the last 
group typically have spent a relatively large amount 
of time in hospitals and other medical facilities, 
which may further increase the risk for nasal colo- 
nization. 5 
Finally, isolates from five of the six patients 
reported on here had identical susceptibility pat- 
Fig. 1. Deoxyribonucleic acid fingerprints obtained for 
Staphylococcus aureus strains by PFGE of Sinai-digested 
bacterial deoxyribonucleic acid. Lowercase lambda (~t) indi- 
cates molecular size markers. Isolates from patients 1 
through 6 are labeled according to source: nares, N,"sternal 
wound, W," blood culture B; skin S; venous catheter site, C. 
terns. They were all resistant o ampicillin but 
uniformly sensitive to all other antibiotics tested, 
including mupirocin. This fact also underlines the 
importance of molecular typing methods to distin- 
guish among isolates and to determine whether 
further epidemiologic investigations focusing on 
nosocomial transmission are needed. This report 
shows that rapid investigation with molecular epide- 
miologic tools allows the clinician to rule out noso- 
comial transmission ofS. aureus between patients. A
time-consuming epidemiologic nvestigation of pos- 
sible risk factors and modes of transmission was thus 
avoided in four cases, and efforts could be concen- 
trated on the investigation of possible links between 
the other two patients. In addition, the discrimina- 
tory power of genetic fingerprinting clearly estab- 
lished the distinctness of isolates from individual 
patients, as well as the identity of various isolates 
recovered from single patients. This information 
formed the basis for the hypothesis that nasal colo- 
nization of pediatric patients undergoing heart op- 
erations may be a risk factor for the development of
surgical site infection. On the basis of our observa- 
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tions, we suggest that the role of nasal colonization 
with S. aureus as a predisposing factor for postop- 
erative infections in pediatric patients undergoing 
heart operations hould be evaluated in a prospec- 
tive study and that this study should include research 
into the effects of mupirocin on the rate of postop- 
erative infections in colonized patients. 
We are indebted to the surgeons of the Clinic for 
Cardiovascular Surgery at the University Hospital of 
Zurich, under the leadership of Professor M. Turina, and 
to Ms. Silvia Fr6hlich and Ms. Claudia Vanoli for techni- 
cal assistance in identification and molecular typing of the 
isolates. 
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